OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Pioneering Pain Management with Botulinum Toxin Type A: From Anti-Inflammation to Regenerative Therapies
Hamta Rahmatipour, Salar Mohammadi Shabestari, Soheila Zamanlui Benisi, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42350-e42350
Open Access | Times Cited: 1

The Treatment of Painful Diabetic Neuropathy
Gordon Sloan, Uazman Alam, Dinesh Selvarajah, et al.
Current Diabetes Reviews (2021) Vol. 18, Iss. 5
Closed Access | Times Cited: 42

A Systematic Guideline by the ASPN Workgroup on the Evidence, Education, and Treatment Algorithm for Painful Diabetic Neuropathy: SWEET
Dawood Sayed, Timothy R. Deer, Jonathan M. Hagedorn, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 1461-1501
Open Access | Times Cited: 7

A Systematic Review and Meta-Analysis of Efficacy of Botulinum Toxin A for Neuropathic Pain
Anupam Datta Gupta, Suzanne Edwards, Jessica C. Smith, et al.
Toxins (2022) Vol. 14, Iss. 1, pp. 36-36
Open Access | Times Cited: 26

Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials
Lorenzo Lippi, Alessandro de Sire, Arianna Folli, et al.
Toxins (2022) Vol. 14, Iss. 5, pp. 308-308
Open Access | Times Cited: 22

Efficacy and safety of botulinum A toxin for the treatment of chronic peripheral neuropathic pain: A systematic review of randomized controlled trials and meta‐analysis
Vincent Hary, Sébastien Schitter, V. Martinez
European Journal of Pain (2022) Vol. 26, Iss. 5, pp. 980-990
Closed Access | Times Cited: 20

American Society of Pain and Neuroscience Best Practice (ASPN) Guideline for the Treatment of Sacroiliac Disorders
Dawood Sayed, Timothy R. Deer, Vinicius Tieppo Francio, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 1601-1638
Open Access | Times Cited: 4

Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain
Ana Bagüés, Jiaxin Hu, Ishraq Alshanqiti, et al.
Pharmacology & Therapeutics (2024) Vol. 259, pp. 108668-108668
Closed Access | Times Cited: 4

Ukrainian National Consensus on Botulinum Therapy for Neuropathic Pain
Vadym Biloshytsky, Maryna Biloshytska, Anatolii I. Gavretskyi, et al.
Ukrainian Neurosurgical Journal (2025) Vol. 31
Open Access

The Effect of Intradermal Botulinum Toxin a injections on painful diabetic polyneuropathy
Mehrdad Taheri, Meghdad Sedaghat, Ali Solhpour, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 6, pp. 1823-1828
Closed Access | Times Cited: 21

Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients
Mohammadreza Davoudi, Parnian Rezaei, Fereshteh Rajaeiramsheh, et al.
Health and Quality of Life Outcomes (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 19

Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review
Matteo Val, Robert Delcanho, Marco Ferrari, et al.
Toxins (2023) Vol. 15, Iss. 9, pp. 541-541
Open Access | Times Cited: 7

The efficacy of botulinum toxin in neuropathic pain: a systematic review
Kaísa Menezes Oliveira, Eduardo Silva Reis Barreto, Vinicius Borges Alencar, et al.
British Journal of Pain (2024) Vol. 18, Iss. 5, pp. 388-402
Closed Access | Times Cited: 2

Role of microglia in diabetic neuropathic pain
Qian Wang, Yilin Xie, Shichao Ma, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

Botulinum Toxin Type A for Diabetic Peripheral Neuropathy Pain: A Systematic Review and Meta-Analysis
Chengbing Wang, Qian Zhang, Renjie Wang, et al.
Journal of Pain Research (2021) Vol. Volume 14, pp. 3855-3863
Open Access | Times Cited: 14

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
Nicoletta Cinone, Luigi Santoro, Stefania Spina, et al.
Toxins (2022) Vol. 14, Iss. 10, pp. 675-675
Open Access | Times Cited: 6

A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury
Celine Lakra, Helen S. Cohen
Journal of Spinal Cord Medicine (2020) Vol. 45, Iss. 5, pp. 651-655
Open Access | Times Cited: 8

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
Cornelius James Fernandez
SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital (2022)
Open Access | Times Cited: 4

A Detailed Review of Various Herbal Treatment Options for Potentially Curing or Ameliorating Pain in Diabetic Neuropathy
Pranay Wal, Priya Singh, Aparna Sinha
Current Traditional Medicine (2022) Vol. 9, Iss. 2
Closed Access | Times Cited: 4

Pain Disorders other than Migraine
Bahman Jabbari
Springer eBooks (2024), pp. 57-86
Closed Access

The Impact of Diabetes on Aesthetic Procedures
Klaus Fritz, Carmen Sălăvăstru, Seher Eren, et al.
Springer eBooks (2024), pp. 351-368
Closed Access

Einfluss von Diabetes auf ästhetische Eingriffe
Klaus Fritz, Carmen Sălăvăstru, Seher Eren, et al.
Deleted Journal (2024)
Closed Access

The Efficacy of Intradermal Injection of Botulinum Toxin Type-A on Painful Diabetic Neuropathy: A Systematic Review
Masume Bayat, Seyed Ahmad Raeissadat, Fateme Hojjati, et al.
Anesthesiology and Pain Medicine (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top